Life Sciences Research is selling itself too cheaply - for $8.50 a share - to Lion Holdings, which is controlled by Life Sciences' CEO Andrew Baker, shareholders claim in Somerset County Court, N.J.
Immersion Corp. inflated its share price through false and misleading statements, shareholders claim in San Francisco Federal Court.
Categories / Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.
Additional Reads
-
-
Texans head to the polls for high-stakes US Senate primary February 17, 2026